Cost-effectiveness analysis of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy in Mexico

被引：0
|
作者：
Arreola-Ornelas, H. [1 ]
Dorantes-Aguilar, J. [1 ]
Garcia-Mollinedo, M. D. L. [2 ]
Rosado-Buzzo, A. A. [2 ]
Mould-Quevedo, J. [3 ]
Davila-Loaiza, G. [3 ]
机构：
[1] Fdn Mexicana Salud, Mexico City, DF, Mexico
[2] Links & Links SA CV, Mexico City, DF, Mexico
[3] Pfizer Mexico, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70069-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A17 / A18
页数：2
相关论文
共 50 条
  • [31] Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy
    B. Rodríguez-Sánchez
    L. M. Peña-Longobardo
    A. J. Sinclair
    [J]. The European Journal of Health Economics, 2020, 21 : 335 - 349
  • [32] Cost analysis of adding pregabalin or gabapentin to the management of community-treated patients with peripheral neuropathic pain
    Sicras-Mainar, Antoni
    Rejas-Gutierrez, Javier
    Navarro-Artieda, Ruth
    Planas-Comes, Albert
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (06) : 1170 - 1179
  • [33] Pregabalin for relief of neuropathic pain associated with diabetic neuropathy:: A randomized, double-blind study
    Toelle, Thomas
    Freynhagen, Rainer
    Versavel, Mark
    Trostmann, Uwe
    Young, James P., Jr.
    [J]. EUROPEAN JOURNAL OF PAIN, 2008, 12 (02) : 203 - 213
  • [34] Pregabalin significantly reduces the pain associated with diabetic peripheral neuropathy by day one of treatment
    Stacey, B
    Rosenstock, J
    Freeman, R
    Young, J
    De Cruz, ED
    Emir, B
    Griesing, T
    [J]. DIABETES, 2005, 54 : A149 - A149
  • [35] Emerging drugs for diabetic peripheral neuropathy and neuropathic pain
    Papanas, Nikolaos
    Ziegler, Dan
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 393 - 407
  • [36] COST-EFFECTIVENESS ANALYSIS OF DIABETIC NEPHROPATHY MANAGEMENT
    Alenzi, E. O.
    Kamal, K.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A204 - A204
  • [37] Sustained, long-term efficacy of pregabalin as treatment of neuropathic pain associated with diabetic peripheral neuropathy and post-herpetic neuralgia
    Portenoy, R.
    Sharma, U.
    Young, J.
    LaMoreaux, L.
    Chartier, K.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 137 - 137
  • [38] Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
    Igarashi, Ataru
    Akazawa, Manabu
    Murata, Tatsunori
    Taguchi, Toshihiko
    Sadosky, Alesia
    Ebata, Nozomi
    Willke, Richard
    Fujii, Koichi
    Doherty, Jim
    Kobayashi, Makoto
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 505 - 520
  • [39] Substitution of Gabapentin Therapy with Pregabalin Therapy in Neuropathic Pain due to Peripheral Neuropathy
    Toth, Cory
    [J]. PAIN MEDICINE, 2010, 11 (03) : 456 - 465
  • [40] Acupuncture and Moxibustion for Peripheral Neuropathic Pain: A Frequentist Network Meta-Analysis and Cost-Effectiveness Evaluation
    Zhao, Weixuan
    Huang, Haoming
    Liu, Kun
    Wang, Shuxin
    Lin, Shiyu
    Long, Wenjie
    Li, Lixia
    Zeng, Jingchun
    Lin, Guohua
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
12345